Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression

Cell Biology International

Volumn 34, Issue 6, 2010, Pages 601-605

  Rabani, Vahideh ^a   Shahsavani, Mansoureh ^b   Gharavi, Marzieh ^b   Piryaei, Abbas ^a,c   Azhdari, Zahra ^a   Baharvand, Hossein ^a,d  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^b LEGAL MEDICINE RESEARCH CENTER   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF SCIENCE AND CULTURE   (Iran)

Author keywords

Liver fibrosis model; Matrix metalloproteinase; Mesenchymal stem cell; Mouse

Indexed keywords

ALBUMIN; ALPHA SMOOTH MUSCLE ACTIN; CARBON TETRACHLORIDE; COLLAGEN; COLLAGENASE 3; GELATINASE B; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; ACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GRAFT RECIPIENT; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER FIBROSIS; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; BONE MARROW CELL; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DISEASE MODEL; ENZYMOLOGY; GENETICS; LIVER CIRRHOSIS; MESENCHYMAL STEM CELL; METABOLISM;

ACTINS; ANIMALS; BONE MARROW CELLS; CARBON TETRACHLORIDE; COLLAGEN; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; LIVER CIRRHOSIS; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 9; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; UP-REGULATION;

EID: 77955062426     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20090386     Document Type: Article

References (24)

1. Abdel Aziz MT, Atta HM, Mahfouz S, Fouad HH, Roshdy NK, Ahmed HH et al. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Biochem 2007;40:893-9.
2. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M et al. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J Gastroenterol Hepatol 2009;24:70-7.
3. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M et al. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells 2008;26:2705-12.
4. Bruckner K, Perez L, Clausen H, Cohen S. Glycosyltransferase activity of Fringe modulates Notch-Delta interactions. Nature 2000;406:411-5.
5. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006;98:1076-84.
6. Carvalho AB, Quintanilha LF, Dias JV, Paredes BD, Mannheimer EG, Carvalho FG et al. Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury. Stem Cells 2008;26:1307-14.
7. di Bonzo LV, Ferrero I, Cravanzola C, Mareschi K, Rustichell D, Novo E et al. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut 2008;57:223-31.
8. Duncan AW, Dorrell C,Grompe M. Stem cells and liver regeneration. Gastroenterology 2009;137(2):466-81.
9. Fallowfield JA, Mizuno M, Kendall TJ, Constandinou CM, Benyon RC, Duffield JS et al. Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol 2007;178:5288-95.
10. Friedman SL. Liver fibrosis: from bench to bedside. J Hepatol 2003;38 Suppl 1:S38-53.
11. Inagaki Y, Higashiyama R, Okazaki I. Treatment strategy for liver fibrosis through recruitment and differentiation of bone marrow stem/progenitor cells. Hepatol Res 2007;37:991-3.
12. Janakat S, Al-Merie H. Optimization of the dose and route of injection, and characterisation of the time course of carbon tetrachlorideinduced hepatotoxicity in the rat. J Pharmacol Toxicol Methods 2002;48:41-4.
13. Jung KH, Shin HP, Lee S, Lim YJ, Hwang SH, Han H et al. Effect of human umbilical cord blood-derived mesenchymal stem cells in a cirrhotic rat model. Liver Int 2009;29:898-909.
14. Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YR, Fang SC et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 2008;134:2111-21.
15. Liang L, Ma T, Chen W, Hu J, Bai X, Li J et al. Therapeutic potential and related signal pathway of adipose-derived stem cell transplantation for rat liver injury. Hepatol Res 2009;39:822-32.
16. 4-injured rats. J Hepatol 2006;44: 742-8.
17. Roderfeld M, Weiskirchen R, Wagner S, Berres ML, Henkel C, Grotzinger J et al. Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice. FASEB J 2006;20:444-54.
18. Russo FP, Alison MR, Bigger BW, Amofah E, Florou A, Amin F et al. The bone marrow functionally contributes to liver fibrosis. Gastroenterology 2006;130:1807-21.
19. Sato Y, Araki H, Kato J, Nakamura K, Kawano Y, Kobune M et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005;106:756-63.
20. Snykers S, Henkens T, De Rop E, Vinken M, Fraczek J, De Kock J et al. Role of epigenetics in liver-specific gene transcription, hepatocyte differentiation and stem cell reprogrammation. J Hepatol 2009;51:187-211.
21. Tsai PC, Fu TW, Chen YM, Ko TL, Chen TH, Shih YH et al. The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis. Liver Transpl 2009;15:484-95.
22. van Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, Tilles AW et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2008;47:1634-43.
23. Wang L, Potter JJ, Rennie-Tankersley L, Novitskiy G, Sipes J, Mezey E. Effects of retinoic acid on the development of liver fibrosis produced by carbon tetrachloride in mice. Biochim Biophys Acta 2007;1772:66-71.
24. Zhou X, Hovell CJ, Pawley S, Hutchings MI, Arthur MJ, Iredale JP et al. Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis. Liver Int 2004;24(5):492-501.